Literature DB >> 20518078

Prediction of disease course in inflammatory bowel diseases.

Peter Laszlo Lakatos.   

Abstract

Clinical presentation at diagnosis and disease course of both Crohn's disease (CD) and ulcerative colitis are heterogeneous and variable over time. Since most patients have a relapsing course and most CD patients develop complications (e.g. stricture and/or perforation), much emphasis has been placed in the recent years on the determination of important predictive factors. The identification of these factors may eventually lead to a more personalized, tailored therapy. In this TOPIC HIGHLIGHT series, we provide an update on the available literature regarding important clinical, endoscopic, fecal, serological/routine laboratory and genetic factors. Our aim is to assist clinicians in the everyday practical decision-making when choosing the treatment strategy for their patients suffering from inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518078      PMCID: PMC2880769          DOI: 10.3748/wjg.v16.i21.2589

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

Review 1.  Role of endoscopy in predicting the disease course in inflammatory bowel disease.

Authors:  Matthieu Allez; Marc Lémann
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

2.  Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.

Authors:  Marla Cindy Dubinsky
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

Review 3.  Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Authors:  Franco Scaldaferri; Carmen Correale; Antonio Gasbarrini; Silvio Danese
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

4.  Do clinical factors help to predict disease course in inflammatory bowel disease?

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

5.  Role of genetics in prediction of disease course and response to therapy.

Authors:  Severine Vermeire; Gert Van Assche; Paul Rutgeerts
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

6.  Is the disease course predictable in inflammatory bowel diseases?

Authors:  Peter Laszlo Lakatos; Lajos S Kiss
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

7.  Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.

Authors:  E Louis; A Collard; A F Oger; E Degroote; F A Aboul Nasr El Yafi; J Belaiche
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

8.  Natural history of pediatric Crohn's disease: a population-based cohort study.

Authors:  Gwenola Vernier-Massouille; Mamadou Balde; Julia Salleron; Dominique Turck; Jean Louis Dupas; Olivier Mouterde; Véronique Merle; Jean Louis Salomez; Julien Branche; Raymond Marti; Eric Lerebours; Antoine Cortot; Corinne Gower-Rousseau; Jean Frédéric Colombel
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

9.  Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.

Authors:  Kelly M Tarrant; Murray L Barclay; Christopher M A Frampton; Richard B Gearry
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

10.  Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

Authors:  Inger Camilla Solberg; Idar Lygren; Jørgen Jahnsen; Erling Aadland; Ole Høie; Milada Cvancarova; Tomm Bernklev; Magne Henriksen; Jostein Sauar; Morten H Vatn; Bjørn Moum
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

  10 in total
  4 in total

Review 1.  Current treatment of ulcerative colitis.

Authors:  Johannes Meier; Andreas Sturm
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

2.  International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study.

Authors:  Martine A Aardoom; Polychronis Kemos; Irma Tindemans; Marina Aloi; Sibylle Koletzko; Arie Levine; Dan Turner; Gigi Veereman; Mattias Neyt; Richard K Russell; Thomas D Walters; Frank M Ruemmele; Janneke N Samsom; Nicholas M Croft; Lissy de Ridder
Journal:  BMJ Open       Date:  2020-07-01       Impact factor: 2.692

3.  Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare's Milk in the Treatment of Dysbiosis.

Authors:  Samat Kozhakhmetov; Dmitriy Babenko; Saniya Kozhakhmetova; Altynay Tuyakova; Madiyar Nurgaziyev; Ayaulym Nurgozhina; Nurislam Muhanbetganov; Laura Chulenbayeva; Shynggys Sergazy; Alexander Gulyayev; Mohamad Aljofan; Almagul Kushugulova
Journal:  Biomed Res Int       Date:  2022-01-29       Impact factor: 3.411

Review 4.  Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases.

Authors:  Jason Reinglas; Lorant Gonczi; Zsuzsanna Kurt; Talat Bessissow; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.